肠道微生物群与妊娠激素代谢物在妊娠糖尿病中相互作用
Xuejing Lyu1,2, Shaona Wang3,4, Jiaxin Zhong2
1Clinical Medical Research Center for Obstetrics and Gynecology Diseases of Fujian Province, Laboratory of Research and Diagnosis of Gynecological Diseases of Xiamen City, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Frontiers in microbiology
|July 26, 2023
概括
肠道微生物组合的变化与妊娠期糖尿病 (GDM) 有关. 我们的研究表明,肠道细菌影响妊娠激素代谢,为GDM发育和潜在的早期诊断生物标志物提供了新的见解.
科学领域:
- 微生物学 微生物学
- 代谢障碍 代谢障碍 代谢障碍
- 怀孕研究 怀孕研究
背景情况:
- 肠道微生物群失生症越来越多地与代谢疾病有关.
- 孕期糖尿病 (GDM) 是一种严重的妊娠并发症,对母亲和孩子的健康有潜在的长期影响.
研究的目的:
- 调查肠道微生物组合在GDM发展中的作用.
- 为了确定与GDM病理生理学相关的特定微生物和代谢变化.
主要方法:
- 使用16S rRNA基因测序,分析了有或没有GDM的孕妇的肠道微生物组.
- 进行了有针对性的代谢学测试,以识别和验证关键代谢物.
- 测量特定代谢物和激素的血清水平在独立的队列中进行验证.
主要成果:
- 在患有GDM的女性中,在操作分类学单位 (OTU) 和132个代谢途径中发现了显著的变化.
- 丁酸盐和甲被确定为过度表现的代谢物,可能将肠道微生物群与GDM联系起来.
- 血清中孕激素,雌激素,丁酸盐和甲酸盐水平的持续变化证实了微生物群对GDM的影响.
结论:
- 肠道微生物群的变化通过影响怀孕激素代谢,有助于GDM的发病.
- 这项研究为GDM发展提供了新的视角.
- 已识别的代谢物可以作为早期GDM诊断和预防的潜在生物标志物.
相关概念视频
Pathophysiology of Diabetes
996
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
996
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Glucagon-like Receptor Agonists
358
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
358
Oral Hypoglycemic Agents: Biguanides and Glitazones
234
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234
Anatomy of the Intestines
72.5K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.5K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


